NCT00783380 - Influenza Vaccination in Immunocompromized Patients | Biotech Hunter

Enrollment

304

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

July 31, 2006

Study Completion Date

March 31, 2008

Conditions

Immunosuppression

Interventions

BIOLOGICAL

Virosomal influenza vaccine

Influvacplus 2005/2006, Solvay Pharma AG, Bern, Switzerland Assigned to all 4 groups if immunocompromized patients

BIOLOGICAL

Subunit influenza vaccine

Influvac 2005/2006, Solvay Pharma AG, Bern, Switzerland Assigned to all 4 groups if immunocompromized patients

Trial Locations (3)

Department of Infectious Diseases, Bern University Hospital, Bern

Department of Nephrology/Hypertension, Bern University Hospital, Bern

Department of Rheumatic Diseases, Bern University Hospital, Bern